Eli Lilly raises price of diabetes drug Mounjaro in UK ahead of Trump deadline

Lily, the best performing stock in the S&P today, up nearly 4%. The company announcing it is raising the lift price of its blockbuster diabetes drug, Monaro, in the UK. President Trump has been pressuring big pharma to get US drug prices more in line with the rest of the world most favored nation status.Let's bring in Dr. . Kavita Patel, who's an NBC News and MSNBC medical contributor. She served in the office of intergovernmental affairs and public engagement under President Obama.Dr. . Patel, great to see ...